News Focus
News Focus
icon url

Gus1212

03/30/25 12:39 AM

#757240 RE: SkyLimit2022 #757232

I can't help thinking that Merck will either buy us out or buy access.

The latest discover about subcutaneous Keytruda says it all.

Keytruda patents will be extended!

I hope we get shares

This is my opinion and it will not change until we read differently.
Bullish
Bullish